Chongqing Zhifei Biological Products Co Stock | 300122.SZ | CNE100000V20 |

Date	Chongqing Zhifei Biological Products Co Price
2/28/2025	25.10 undefined
2/27/2025	26.01 undefined
2/26/2025	26.25 undefined
2/25/2025	26.10 undefined
2/24/2025	26.17 undefined
2/21/2025	26.85 undefined
2/20/2025	26.14 undefined
2/19/2025	25.63 undefined
2/18/2025	25.40 undefined
2/17/2025	26.49 undefined
2/14/2025	25.49 undefined
2/13/2025	25.03 undefined
2/12/2025	25.34 undefined
2/11/2025	25.20 undefined
2/10/2025	25.81 undefined
2/7/2025	25.40 undefined
2/6/2025	24.65 undefined
2/5/2025	24.29 undefined

Date	Chongqing Zhifei Biological Products Co Revenue	Chongqing Zhifei Biological Products Co EBIT	Chongqing Zhifei Biological Products Co Net Income
2026e	37.55 B undefined	7.42 B undefined	6.58 B undefined
2025e	35.62 B undefined	6.29 B undefined	5.03 B undefined
2024e	35.08 B undefined	5.46 B undefined	4.18 B undefined
2023	52.92 B undefined	9.34 B undefined	8.07 B undefined
2022	38.26 B undefined	8.75 B undefined	7.54 B undefined
2021	30.65 B undefined	12.01 B undefined	10.21 B undefined
2020	15.19 B undefined	4.02 B undefined	3.3 B undefined
2019	10.59 B undefined	2.88 B undefined	2.37 B undefined
2018	5.23 B undefined	1.72 B undefined	1.45 B undefined
2017	1.34 B undefined	500 M undefined	432 M undefined
2016	446 M undefined	11 M undefined	33 M undefined
2015	713 M undefined	191 M undefined	197 M undefined
2014	801 M undefined	148 M undefined	148 M undefined
2013	780 M undefined	123 M undefined	130 M undefined
2012	760 M undefined	180 M undefined	215 M undefined
2011	629 M undefined	155 M undefined	196 M undefined
2010	737 M undefined	288 M undefined	257 M undefined
2009	604 M undefined	257 M undefined	232 M undefined
2008	590 M undefined	221 M undefined	190 M undefined
2007	492 M undefined	180 M undefined	152 M undefined

	Revenue	EBIT	Net Income
2007	492 M CNY	180 M CNY	152 M CNY
2008	590 M CNY	221 M CNY	190 M CNY
2009	604 M CNY	257 M CNY	232 M CNY
2010	737 M CNY	288 M CNY	257 M CNY
2011	629 M CNY	155 M CNY	196 M CNY
2012	760 M CNY	180 M CNY	215 M CNY
2013	780 M CNY	123 M CNY	130 M CNY
2014	801 M CNY	148 M CNY	148 M CNY
2015	713 M CNY	191 M CNY	197 M CNY
2016	446 M CNY	11 M CNY	33 M CNY
2017	1.34 B CNY	500 M CNY	432 M CNY
2018	5.23 B CNY	1.72 B CNY	1.45 B CNY
2019	10.59 B CNY	2.88 B CNY	2.37 B CNY
2020	15.19 B CNY	4.02 B CNY	3.3 B CNY
2021	30.65 B CNY	12.01 B CNY	10.21 B CNY
2022	38.26 B CNY	8.75 B CNY	7.54 B CNY
2023	52.92 B CNY	9.34 B CNY	8.07 B CNY
2024e	35.08 B CNY	5.46 B CNY	4.18 B CNY
2025e	35.62 B CNY	6.29 B CNY	5.03 B CNY
2026e	37.55 B CNY	7.42 B CNY	6.58 B CNY

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.49	0.59	0.6	0.74	0.63	0.76	0.78	0.8	0.71	0.45	1.34	5.23	10.59	15.19	30.65	38.26	52.92	35.08	35.62	37.55
-	19.92	2.37	22.02	-14.65	20.83	2.63	2.69	-10.99	-37.45	201.12	289.28	102.51	43.48	101.79	24.83	38.29	-33.70	1.54	5.40
56.50	62.03	67.22	62.01	58.66	55.39	56.41	60.05	79.52	87.00	76.17	54.51	41.87	38.68	48.73	33.34	26.33	39.71	39.11	37.10
0.28	0.37	0.41	0.46	0.37	0.42	0.44	0.48	0.57	0.39	1.02	2.85	4.43	5.88	14.94	12.76	13.93	0	0	0
0.15	0.19	0.23	0.26	0.2	0.22	0.13	0.15	0.2	0.03	0.43	1.45	2.37	3.3	10.21	7.54	8.07	4.18	5.03	6.58
-	25.00	22.11	10.78	-23.74	9.69	-39.53	13.85	33.11	-83.25	1,209.09	235.88	63.06	39.52	209.24	-26.15	7.03	-48.15	20.15	30.95
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.01	0.08	1.44	1.48	1.6	1.6	1.6	1.6	1.6	1.6	1.6	1.6	1.6	1.6	2.4	2.4	2.4	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.14	0.06	0.18	1.62	1.45	1.27	1.21	1.02	0.81	0.66	0.87	0.56	0.91	1.39	4.28	2.62	6.34
0.04	0.06	0.07	0.3	0.26	0.3	0.3	0.31	0.32	0.3	0.7	1.98	4.44	6.62	12.87	20.61	27.06
70	21	4	7	62	66	76	120	119	60	59	62	63	9	6.87	8.39	7.8
0.01	0.03	0.03	0.08	0.16	0.23	0.16	0.15	0.11	0.1	0.63	1.78	2.48	3.41	7.39	8.02	8.99
29	78	60	13	34	3	4	13	8	16	24	236	271	107	214.27	154.91	122.33
0.29	0.26	0.35	2.01	1.96	1.87	1.75	1.62	1.36	1.14	2.29	4.62	8.17	11.54	24.75	31.41	42.51
0.04	0.07	0.07	0.08	0.13	0.34	0.52	0.76	0.97	1.11	1.26	1.53	1.98	2.39	3.56	4.69	5.12
0	0	2	1	1	1	1	11	8	17	37	51	101	182	249.93	294.65	295.27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.87	8.39	0
0.01	0.05	0.07	0.08	0.27	0.26	0.27	0.28	0.29	0.3	0.3	0.38	0.46	0.64	0.79	1.06	1.32
0	19	19	19	19	19	19	19	19	19	19	19	19	19	19.28	19.28	19.28
1	1	18	17	18	16	28	27	38	129	201	222	217	455	679.83	526.66	960.33
0.05	0.14	0.17	0.2	0.44	0.64	0.84	1.1	1.32	1.57	1.82	2.19	2.78	3.68	5.3	6.6	7.72
0.33	0.39	0.52	2.21	2.4	2.5	2.59	2.72	2.68	2.71	4.11	6.81	10.94	15.22	30.05	38.01	50.23

0	0.02	0.36	0.4	0.4	0.4	0.4	0.8	0.8	1.6	1.6	1.6	1.6	1.6	1.6	1.6	2.4
0.01	0	0.02	1.41	1.41	1.41	1.41	1.01	1.01	0.21	0.21	0.21	0.21	0.21	0.21	0.21	0.05
0.18	0.25	0.08	0.33	0.45	0.57	0.58	0.64	0.76	0.71	1.13	2.37	3.94	6.44	15.85	22.43	29.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.19	0.27	0.45	2.14	2.26	2.37	2.39	2.46	2.57	2.52	2.94	4.18	5.75	8.25	17.66	24.24	31.51
0.02	0.01	0	0	0.01	0.01	0.02	0.03	0.07	0.05	0.64	1.63	2.21	3.03	9.15	9.79	13.14
0	0	0	0	0	0.01	0.01	0.01	0.01	0.01	0.03	0.11	0.29	0.41	0.9	0.98	1.32
0.13	0.1	0.04	0.05	0.04	0.03	0.03	0.03	0.04	0.03	0.09	0.16	0.17	0.44	1.22	0.65	0.94
0	0.01	0.01	0	0.08	0.06	0.08	0.06	0	0	0.31	0.65	2.39	2.93	0.6	1.8	2.64
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.25	9.81	46.61
0.14	0.11	0.05	0.05	0.13	0.11	0.14	0.13	0.13	0.1	1.07	2.54	5.07	6.82	11.87	13.23	18.09
0	0	0	0	0	0	0	54	0	0	0	0	0	0	248.65	238.41	353.39
0	6	5	5	5	4	4	3	3	3	2	2	25	30	48.34	60.77	57.96
2	6	10	11	13	20	57	68	84	85	97	92	98	120	222.2	238.34	228.27
2	12	15	16	18	24	61	125	87	88	99	94	123	150	519.19	537.52	639.62
0.14	0.12	0.07	0.07	0.15	0.13	0.2	0.26	0.21	0.19	1.17	2.63	5.2	6.97	12.39	13.77	18.73
0.33	0.39	0.52	2.21	2.4	2.51	2.59	2.71	2.78	2.71	4.11	6.81	10.94	15.22	30.05	38	50.23

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.21	7.54
0	0	0	0	0	0	0	0	0	0	0	0	0	0	487	351
0	0	0	0	0	0	0	0	0	0	0	0	0	0	27	-58
-44	-68	-106	-100	-77	-150	-206	-286	-321	-305	-434	-991	-1,351	-1,580	-2,481	-3,068
0	0	0	0	0	0	0	0	0	0	0	0	0	0	346	587
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-91	-131	-113	-114	-114	-85	-81	-67	-66	-44	-102	-384	-732	-875	-1,954	-3,274
0.11	0.14	0.21	0.05	0.22	0.11	0.22	0.16	0.22	0.09	0.2	0.59	1.37	3.5	8.51	1.99
-24	-35	-11	-51	-309	-199	-201	-277	-225	-308	-230	-479	-572	-827	-1,932	-1,453
-34	-136	-43	-39	-306	-194	-198	-336	-336	-151	-250	-493	-622	-896	-2,019	-1,497
-10	-100	-31	12	3	4	3	-60	-110	156	-19	-13	-49	-69	-87	-44
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-5	0	3	-8	0	0	0	54	-54	0	260	51	492	-1,379	-2,742	-1,165
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.01	-0.08	-0.05	1.42	-0.08	-0.1	-0.08	-0.01	-0.21	0.02	0.14	-0.29	-0.39	-2.11	-3.59	-2.17
0	0	-0	1.43	-0.01	-0.01	0.03	0.01	-0.08	0.1	-0.09	-0.11	-0.01	0.19	0.01	0.01
-8	-83	-46	0	-72	-90	-110	-80	-82	-80	-23	-234	-870	-928	-861	-1,015
0.31	0.27	0.55	1.7	0.25	0.17	0.45	0.33	0.28	0.4	0.83	1.77	3.8	6.43	15.83	6.67
86.9	105.7	198.7	2.7	-88.4	-86.2	20.2	-115.6	-2.3	-218	-27.2	105.8	794.1	2,669.7	6,575.48	535.93
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Chongqing Zhifei Biological Products Co Gross margin	Chongqing Zhifei Biological Products Co Profit margin	Chongqing Zhifei Biological Products Co EBIT margin	Chongqing Zhifei Biological Products Co Profit margin
2026e	26.33 %	19.76 %	17.53 %
2025e	26.33 %	17.64 %	14.11 %
2024e	26.33 %	15.55 %	11.93 %
2023	26.33 %	17.66 %	15.25 %
2022	33.35 %	22.87 %	19.7 %
2021	48.73 %	39.18 %	33.3 %
2020	38.68 %	26.46 %	21.73 %
2019	41.87 %	27.17 %	22.35 %
2018	54.51 %	32.94 %	27.75 %
2017	76.17 %	37.23 %	32.17 %
2016	87 %	2.47 %	7.4 %
2015	79.52 %	26.79 %	27.63 %
2014	60.05 %	18.48 %	18.48 %
2013	56.41 %	15.77 %	16.67 %
2012	55.39 %	23.68 %	28.29 %
2011	58.66 %	24.64 %	31.16 %
2010	62.01 %	39.08 %	34.87 %
2009	67.22 %	42.55 %	38.41 %
2008	62.03 %	37.46 %	32.2 %
2007	56.5 %	36.59 %	30.89 %

	Gross margin	EBIT margin	Profit margin
2007	56.5 %	36.59 %	30.89 %
2008	62.03 %	37.46 %	32.2 %
2009	67.22 %	42.55 %	38.41 %
2010	62.01 %	39.08 %	34.87 %
2011	58.66 %	24.64 %	31.16 %
2012	55.39 %	23.68 %	28.29 %
2013	56.41 %	15.77 %	16.67 %
2014	60.05 %	18.48 %	18.48 %
2015	79.52 %	26.79 %	27.63 %
2016	87 %	2.47 %	7.4 %
2017	76.17 %	37.23 %	32.17 %
2018	54.51 %	32.94 %	27.75 %
2019	41.87 %	27.17 %	22.35 %
2020	38.68 %	26.46 %	21.73 %
2021	48.73 %	39.18 %	33.3 %
2022	33.35 %	22.87 %	19.7 %
2023	26.33 %	17.66 %	15.25 %
2024e	26.33 %	15.55 %	11.93 %
2025e	26.33 %	17.64 %	14.11 %
2026e	26.33 %	19.76 %	17.53 %

Date	Chongqing Zhifei Biological Products Co Sales per Share	Chongqing Zhifei Biological Products Co EBIT per share	Chongqing Zhifei Biological Products Co Earnings per Share
2026e	15.69 undefined	0 undefined	2.75 undefined
2025e	14.88 undefined	0 undefined	2.1 undefined
2024e	14.66 undefined	0 undefined	1.75 undefined
2023	22.05 undefined	3.89 undefined	3.36 undefined
2022	15.94 undefined	3.65 undefined	3.14 undefined
2021	12.77 undefined	5 undefined	4.25 undefined
2020	9.49 undefined	2.51 undefined	2.06 undefined
2019	6.62 undefined	1.8 undefined	1.48 undefined
2018	3.27 undefined	1.08 undefined	0.91 undefined
2017	0.84 undefined	0.31 undefined	0.27 undefined
2016	0.28 undefined	0.01 undefined	0.02 undefined
2015	0.45 undefined	0.12 undefined	0.12 undefined
2014	0.5 undefined	0.09 undefined	0.09 undefined
2013	0.49 undefined	0.08 undefined	0.08 undefined
2012	0.48 undefined	0.11 undefined	0.13 undefined
2011	0.39 undefined	0.1 undefined	0.12 undefined
2010	0.5 undefined	0.19 undefined	0.17 undefined
2009	0.42 undefined	0.18 undefined	0.16 undefined
2008	7.38 undefined	2.76 undefined	2.38 undefined
2007	44.73 undefined	16.36 undefined	13.82 undefined

	Sales per Share	EBIT per share	Earnings per Share
2007	44.73 CNY	16.36 CNY	13.82 CNY
2008	7.38 CNY	2.76 CNY	2.38 CNY
2009	0.42 CNY	0.18 CNY	0.16 CNY
2010	0.5 CNY	0.19 CNY	0.17 CNY
2011	0.39 CNY	0.1 CNY	0.12 CNY
2012	0.48 CNY	0.11 CNY	0.13 CNY
2013	0.49 CNY	0.08 CNY	0.08 CNY
2014	0.5 CNY	0.09 CNY	0.09 CNY
2015	0.45 CNY	0.12 CNY	0.12 CNY
2016	0.28 CNY	0.01 CNY	0.02 CNY
2017	0.84 CNY	0.31 CNY	0.27 CNY
2018	3.27 CNY	1.08 CNY	0.91 CNY
2019	6.62 CNY	1.8 CNY	1.48 CNY
2020	9.49 CNY	2.51 CNY	2.06 CNY
2021	12.77 CNY	5 CNY	4.25 CNY
2022	15.94 CNY	3.65 CNY	3.14 CNY
2023	22.05 CNY	3.89 CNY	3.36 CNY
2024e	14.66 CNY	0 CNY	1.75 CNY
2025e	14.88 CNY	0 CNY	2.1 CNY
2026e	15.69 CNY	0 CNY	2.75 CNY

	Number of stocks
2007	11 M Aktien
2008	80 M Aktien
2009	1.44 B Aktien
2010	1.48 B Aktien
2011	1.6 B Aktien
2012	1.6 B Aktien
2013	1.6 B Aktien
2014	1.6 B Aktien
2015	1.6 B Aktien
2016	1.6 B Aktien
2017	1.6 B Aktien
2018	1.6 B Aktien
2019	1.6 B Aktien
2020	1.6 B Aktien
2021	2.4 B Aktien
2022	2.4 B Aktien
2023	2.4 B Aktien
2024e	2.4 B Aktien
2025e	2.4 B Aktien
2026e	2.4 B Aktien

Date	Chongqing Zhifei Biological Products Co Dividend
2026e	0.42 undefined
2025e	0.42 undefined
2024e	0.42 undefined
2023	0.33 undefined
2022	0.6 undefined
2021	0.5 undefined
2020	0.5 undefined
2019	0.5 undefined
2018	0.13 undefined
2017	0.01 undefined
2016	0.05 undefined
2015	0.05 undefined
2014	0.05 undefined
2013	0.08 undefined
2012	0.06 undefined
2011	0.05 undefined

	Dividend	Dividend (Estimate)
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0.05 CNY	0 CNY
2012	0.06 CNY	0 CNY
2013	0.08 CNY	0 CNY
2014	0.05 CNY	0 CNY
2015	0.05 CNY	0 CNY
2016	0.05 CNY	0 CNY
2017	0.01 CNY	0 CNY
2018	0.13 CNY	0 CNY
2019	0.5 CNY	0 CNY
2020	0.5 CNY	0 CNY
2021	0.5 CNY	0 CNY
2022	0.6 CNY	0 CNY
2023	0.33 CNY	0 CNY
2024e	0 CNY	0.42 CNY
2025e	0 CNY	0.42 CNY
2026e	0 CNY	0.42 CNY

Date	Chongqing Zhifei Biological Products Co Payout ratio
2026e	17.58 %
2025e	17.96 %
2024e	16.41 %
2023	18.38 %
2022	19.1 %
2021	11.75 %
2020	24.27 %
2019	33.78 %
2018	14.29 %
2017	3.7 %
2016	250 %
2015	41.67 %
2014	55.56 %
2013	93.75 %
2012	48.08 %
2011	41.67 %
2010	18.38 %
2009	18.38 %
2008	18.38 %
2007	18.38 %

	Payout ratio
2007	18.38 %
2008	18.38 %
2009	18.38 %
2010	18.38 %
2011	41.67 %
2012	48.08 %
2013	93.75 %
2014	55.56 %
2015	41.67 %
2016	250 %
2017	3.7 %
2018	14.29 %
2019	33.78 %
2020	24.27 %
2021	11.75 %
2022	19.1 %
2023	18.38 %
2024e	16.41 %
2025e	17.96 %
2026e	17.58 %

Date	EPS Estimate	EPS Actual	Quarterly report
9/30/2024	0.82	-0.04 (-104.27 %)	2024 Q3
6/30/2024	0.77	0.32 (-57.74 %)	2024 Q2
3/31/2024	0.94	0.61 (-35.16 %)	2024 Q1
12/31/2023	0.87	0.64 (-26.4 %)	2023 Q4
9/30/2023	0.95	0.95 (-0.67 %)	2023 Q3
6/30/2023	0.92	0.93 (0.72 %)	2023 Q2
3/31/2023	0.77	0.85 (10.65 %)	2023 Q1
12/31/2022	0.78	0.8 (2.66 %)	2022 Q4
9/30/2022	0.81	0.78 (-3.74 %)	2022 Q3
6/30/2022	0.92	0.75 (-18.05 %)	2022 Q2
3/31/2022	0.86	0.8 (-6.31 %)	2022 Q1
12/31/2021	0.53	1.12 (110.2 %)	2021 Q4
9/30/2021	0.99	1.82 (83.42 %)	2021 Q3
6/30/2021	1.19	2.85 (138.74 %)	2021 Q2
12/31/2020	0.46	0.51 (10.63 %)	2020 Q4
12/31/2017	0.1	0.09 (-10.89 %)	2017 Q4
9/30/2017	0.09	0.07 (-22 %)	2017 Q3
6/30/2017	0.07	0.07 (-0.99 %)	2017 Q2
12/31/2011	0.04	0.04 (-4.84 %)	2011 Q4

%	Name	Stocks	Change	Date
48.44090 %	Jiang (Rensheng)	1,159,573,500	0	6/30/2024
5.41401 %	Jiang (Lingfeng)	129,600,000	0	6/30/2024
3.82239 %	Liu (Tieying)	91,500,000	0	6/30/2024
1.71799 %	E Fund Management Co. Ltd.	41,125,091	46,200	6/30/2024
1.56667 %	China Merchants Fund Management Co. Ltd.	37,502,749	-833,400	6/30/2024
0.74103 %	Wu (Guanjiang)	17,738,657	0	6/30/2024
0.73421 %	Shanghai Yingshui Investment Management Co., Ltd.	17,575,500	0	6/30/2024
0.70182 %	Jiang (Xisheng)	16,800,000	0	6/30/2024
0.65055 %	Huatai-PineBridge Fund Management Co., Ltd.	15,572,683	3,735,709	6/30/2024
0.52451 %	Tianhong Asset Management Co., Ltd.	12,555,686	-1,545,450	6/30/2024
0.50850 %	China Asset Management Co., Ltd.	12,172,352	-3,155,894	6/30/2024
0.50278 %	Yinhua Fund Management Co., Ltd.	12,035,599	-2,025,347	6/30/2024
0.46157 %	Zhongtai Securities (Shanghai) Asset Management Co., Ltd.	11,049,075	5,298,204	6/30/2024
0.46064 %	Fullgoal Fund Management Co., Ltd.	11,026,816	5,900,239	6/30/2024
0.44530 %	HuaAn Fund Management Co., Ltd.	10,659,646	-5,691,295	6/30/2024
0.43379 %	GF Fund Management Co., Ltd.	10,383,947	-5,395,415	6/30/2024
0.43138 %	Harvest Fund Management Co., Ltd.	10,326,231	1,520,871	9/30/2024
0.35557 %	JPMorgan Asset Management (Asia Pacific) Limited	8,511,567	-404,700	8/31/2024
0.31036 %	Guotai Asset Management Co., Ltd.	7,429,274	-934,364	6/30/2024
0.27682 %	China Universal Asset Management Co., Ltd.	6,626,589	-3,118,851	6/30/2024
0.21472 %	The Vanguard Group, Inc.	5,139,899	57,100	9/30/2024
0.19890 %	Bosera Asset Management Co., Ltd.	4,761,155	-3,457,588	6/30/2024
0.19793 %	China Southern Asset Management Co. Ltd.	4,738,078	-6,983,655	6/30/2024
0.17188 %	Franklin Templeton Sealand Fund Management Co., Ltd.	4,114,422	3,908,422	6/30/2024
0.15687 %	Essence Fund Management Co., Ltd.	3,755,035	-2,373,951	6/30/2024
0.14960 %	Ping An Fund Management Company Limited	3,581,132	478,150	6/30/2024
0.13861 %	BlackRock Institutional Trust Company, N.A.	3,318,148	-66,600	9/30/2024
0.10770 %	INVESCO Great Wall Fund Management Co. Ltd.	2,578,217	-3,567,727	6/30/2024
0.09827 %	BlackRock Advisors (UK) Limited	2,352,343	86,850	9/30/2024
0.09219 %	Morgan Stanley Investment Management (China) Company Limited.	2,206,900	-2,187,288	6/30/2024
0.08904 %	Penghua Fund Management Co., Ltd.	2,131,509	-3,293,977	6/30/2024
0.07864 %	ICBC Credit Suisse Asset Management Co. Ltd.	1,882,582	-21,308,303	6/30/2024
0.07701 %	Rongtong Fund Management Co., Ltd.	1,843,413	-3,744,436	6/30/2024
0.07602 %	Orient Securities Asset Management Company Limited	1,819,800	-15,547,328	6/30/2024
0.07373 %	Bank of Communications Schroder Fund Management Co., Ltd.	1,765,053	-67,350	6/30/2024
0.06166 %	Caisse de Depot et Placement du Quebec	1,475,948	1,448,198	12/31/2023
0.05987 %	JPMorgan Asset Management (China) Company Limited.	1,433,229	-7,292,771	6/30/2024
0.05754 %	Hwabao WP Fund Management Co., Ltd.	1,377,476	-2,808,300	6/30/2024
0.03893 %	CPP Investment Board	932,000	932,000	3/31/2024
0.03840 %	Dimensional Fund Advisors, L.P.	919,277	-400	8/31/2024
0.03469 %	Bellevue Asset Management AG	830,417	0	9/30/2024
0.03452 %	Great Wall Fund Management Co., Ltd.	826,343	-4,175,510	6/30/2024
0.03410 %	PengYang Asset Management Co., Ltd	816,400	-326,400	6/30/2024
0.03292 %	Dacheng Fund Management Co., Ltd.	787,974	-7,054,377	6/30/2024
0.03025 %	China Asset Management (Hong Kong) Limited	724,156	-10,200	8/31/2024
0.02865 %	Harvest Global Investments Limited	685,936	-3,000	9/30/2024
0.02804 %	Geode Capital Management, L.L.C.	671,273	-2,077	8/31/2024
0.02746 %	Norges Bank Investment Management (NBIM)	657,339	-6,160,614	6/30/2024
0.02694 %	Broad Asset Management Co., Ltd	644,881	496,599	6/30/2024
0.02593 %	DWS Investments UK Limited	620,723	-27,015	9/30/2024
0.02440 %	Wanjia Asset Management Co., Ltd.	584,100	297,450	6/30/2024
0.02138 %	CCB Principal Asset Management Co., Ltd.	511,900	-13,500	7/31/2024
0.02108 %	CITIC Prudential Fund Management Co., Ltd.	504,495	-1,220,911	6/30/2024
0.01998 %	State Street Global Advisors (US)	478,173	-3,028	9/30/2024
0.01874 %	CPIC Fund Management Co., Ltd.	448,509	247,450	6/30/2024
0.01810 %	CICC Fund Management Co Ltd.	433,339	19,159	6/30/2024
0.01672 %	BlackRock (Singapore) Limited	400,285	-2,652	9/30/2024
0.01667 %	MOS Capital	399,046	399,046	6/30/2023
0.01638 %	Amundi (UK)	392,200	-21,000	8/31/2024
0.01566 %	Founder Securities Co., Ltd.	374,854	-1,000	6/30/2024
0.01559 %	Tibet Eastmoney Fund Management Co., Ltd.	373,286	48,400	6/30/2024
0.01529 %	Mellon Investments Corporation	366,100	-6,400	9/30/2024
0.01456 %	Aviva Investors Global Services Limited	348,564	189	9/30/2024
0.01430 %	Maxwealth Fund Management Co., Ltd.	342,430	-629,400	6/30/2024
0.01413 %	Handelsbanken Kapitalf¿rvaltning AB	338,350	0	9/30/2024
0.01399 %	Topsperity Fund Management Co., Ltd.	334,900	311,800	6/30/2024
0.01397 %	Taikang Asset Management Co., Ltd.	334,395	-69,600	6/30/2024
0.01225 %	Western Leadbank Fund Management Co., Ltd.	293,172	-64,350	6/30/2024
0.01116 %	Truvalue Asset Management Co., Ltd.	267,169	88,400	6/30/2024
0.01093 %	UBS Asset Management (UK) Ltd.	261,700	12,600	9/30/2024
0.01079 %	Northern Trust Global Investments Limited	258,300	-56,250	8/31/2024
0.01070 %	Mercer Global Investments Management Ltd	256,250	0	3/31/2024
0.01061 %	State Street Global Advisors (UK) Ltd.	254,059	-1,950	9/30/2024
0.01058 %	Green Fund Management Co., Ltd.	253,150	55,200	6/30/2024
0.01029 %	PGGM Vermogensbeheer B.V.	246,426	106,666	7/31/2024
0.01014 %	UBS SDIC Fund Management Co., Ltd.	242,700	196,400	6/30/2024
0.00970 %	Nuveen LLC	232,220	0	9/30/2024
0.00940 %	Prescient Investment Management (Pty) Ltd.	224,950	15,700	9/30/2024
0.00937 %	Amundi Asset Management, SAS	224,200	19,600	9/30/2024
0.00882 %	Zhong Ou Asset Management Co., Ltd.	211,234	-6,264,014	6/30/2024
0.00881 %	UBS Fund Management (Switzerland) AG	210,850	-10,500	9/30/2024
0.00861 %	Charles Schwab Investment Management, Inc.	206,100	0	9/30/2024
0.00854 %	China Life AMP Asset Management Co., Ltd	204,350	-58,900	6/30/2024
0.00833 %	Changsheng Fund Management Co., Ltd.	199,400	-12,200	6/30/2024
0.00794 %	Krane Funds Advisors, LLC	190,092	5,300	9/30/2024
0.00773 %	Taiping Fund Management Co., Ltd.	185,000	110,100	6/30/2024
0.00766 %	PensionDanmark A/S	183,363	124,267	8/31/2023
0.00752 %	Nordea Investment Management AB (Denmark)	180,000	0	8/31/2024
0.00705 %	Xingyin Fund Management Co., Ltd.	168,750	11,700	6/30/2024
0.00678 %	SWS MU Fund Management Co., Ltd.	162,335	-253,600	6/30/2024
0.00649 %	HSBC Global Asset Management (UK) Limited	155,423	9,000	9/30/2024
0.00642 %	DWS Investment GmbH	153,654	-3,000	9/30/2024
0.00640 %	Hongde Fund Management Co., Ltd.	153,300	93,550	6/30/2024
0.00633 %	Lion Fund Management Co., Ltd.	151,500	-102,312	6/30/2024
0.00623 %	Dimensional Fund Advisors, Ltd.	149,200	4,700	9/30/2024
0.00546 %	Founder Fubon Fund Management Co., Ltd.	130,700	-226,021	6/30/2024
0.00543 %	BOCI-Prudential Asset Management Ltd.	129,950	0	8/31/2024
0.00468 %	BlackRock Investment Management (UK) Ltd.	112,050	0	6/30/2024
0.00465 %	Franklin Advisers, Inc.	111,300	10,000	9/30/2024
0.00464 %	UBS Asset Management (Switzerland)	111,000	0	8/31/2024

What values and corporate philosophy does Chongqing Zhifei Biological Products Co represent?

Chongqing Zhifei Biological Products Co Ltd represents values of innovation, integrity, and excellence. With a strong corporate philosophy focused on producing high-quality biopharmaceutical products, the company is committed to improving public health and providing advanced healthcare solutions. Chongqing Zhifei is dedicated to rigorous research and development, ensuring that their products meet international standards and address pressing medical needs. By prioritizing customer satisfaction and safety, Chongqing Zhifei aims to be a leader in the biotechnology industry, delivering value to both its stakeholders and patients worldwide.

In which countries and regions is Chongqing Zhifei Biological Products Co primarily present?

Chongqing Zhifei Biological Products Co Ltd is primarily present in China.

What significant milestones has the company Chongqing Zhifei Biological Products Co achieved?

Chongqing Zhifei Biological Products Co Ltd has achieved several significant milestones. One notable milestone is the development and successful commercialization of their innovative vaccines. They have also established a strong presence in the global market, with their products being exported to numerous countries. Additionally, the company has focused on research and development, constantly striving to enhance their product portfolio and explore new areas of medicine. Chongqing Zhifei Biological Products Co Ltd has also attained various certifications, including Good Manufacturing Practice (GMP) certification, which highlights their commitment to quality and compliance. Overall, their achievements reflect their dedication to advancing healthcare through cutting-edge biotechnology.

What is the history and background of the company Chongqing Zhifei Biological Products Co?

Chongqing Zhifei Biological Products Co Ltd is a renowned biotechnology company based in Chongqing, China. Established in 1998, the company specializes in the research, development, production, and sale of vaccines. Over the years, Chongqing Zhifei has become a leading player in the biopharmaceutical industry, focusing on the development of preventive vaccines for diseases such as Hepatitis A, Hepatitis E, Japanese Encephalitis, and Varicella. With a strong emphasis on quality, safety, and innovation, Chongqing Zhifei is committed to providing effective and affordable vaccines to improve public health globally. With a rich history and expertise in the field, Chongqing Zhifei is recognized as a trusted name in the biotech sector.

Who are the main competitors of Chongqing Zhifei Biological Products Co in the market?

The main competitors of Chongqing Zhifei Biological Products Co Ltd in the market include Zhengzhou Zhongyuan Bio-Tech Co Ltd, Beijing Tiantan Biological Products Co Ltd, and Chengdu Institute of Biological Products Co Ltd.

In which industries is Chongqing Zhifei Biological Products Co primarily active?

Chongqing Zhifei Biological Products Co Ltd is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of Chongqing Zhifei Biological Products Co?

The business model of Chongqing Zhifei Biological Products Co Ltd revolves around the development, production, and sales of vaccines and biological products. As a leading biotech company in China, Chongqing Zhifei focuses on the research and manufacturing of innovative vaccines for infectious diseases. By leveraging advanced technology and scientific expertise, the company aims to meet the increasing global demand for high-quality vaccines. Chongqing Zhifei is committed to providing effective immunization solutions to improve public health, ensuring their products adhere to stringent quality standards. With a focus on research and development, production, and market expansion, Chongqing Zhifei's business model is centered on delivering sustainable and life-saving healthcare solutions.

What is the P/E ratio of Chongqing Zhifei Biological Products Co 2025?

The Chongqing Zhifei Biological Products Co P/E ratio is 11.98.

What is the P/S ratio of Chongqing Zhifei Biological Products Co 2025?

The Chongqing Zhifei Biological Products Co P/S ratio is 1.69.

What is the Quality Investing of Chongqing Zhifei Biological Products Co?

The Quality Investing for Chongqing Zhifei Biological Products Co is 8/10.

What is the revenue of Chongqing Zhifei Biological Products Co 2025?

The expected Chongqing Zhifei Biological Products Co revenue is 35.62 B CNY.

How high is the profit of Chongqing Zhifei Biological Products Co 2025?

The expected Chongqing Zhifei Biological Products Co profit is 5.03 B CNY.

What is the business model of Chongqing Zhifei Biological Products Co

Chongqing Zhifei Biological Products Co Ltd is a leading company in the field of biological products and medications in the People's Republic of China. The business model is based on the development and production of vaccines and biological products, as well as the distribution of medical devices and pharmaceutical products. Please note that the instructions were not clear. From the given text, it is difficult to determine what specific information should be extracted as the answer.

What is the Chongqing Zhifei Biological Products Co dividend?

Chongqing Zhifei Biological Products Co pays a dividend of 0.6 CNY distributed over payouts per year.

How often does Chongqing Zhifei Biological Products Co pay dividends?

The dividend cannot currently be calculated for Chongqing Zhifei Biological Products Co or the company does not pay out a dividend.

What is the Chongqing Zhifei Biological Products Co ISIN?

The ISIN of Chongqing Zhifei Biological Products Co is CNE100000V20.

What is the Chongqing Zhifei Biological Products Co ticker?

The ticker of Chongqing Zhifei Biological Products Co is 300122.SZ.

How much dividend does Chongqing Zhifei Biological Products Co pay?

Over the past 12 months, Chongqing Zhifei Biological Products Co paid a dividend of 0.33 CNY . This corresponds to a dividend yield of about 1.33 %. For the coming 12 months, Chongqing Zhifei Biological Products Co is expected to pay a dividend of 0.42 CNY.

What is the dividend yield of Chongqing Zhifei Biological Products Co?

The current dividend yield of Chongqing Zhifei Biological Products Co is 1.33 %.

When does Chongqing Zhifei Biological Products Co pay dividends?

Chongqing Zhifei Biological Products Co pays a quarterly dividend. This is distributed in the months of August, July, September, January.

How secure is the dividend of Chongqing Zhifei Biological Products Co?

Chongqing Zhifei Biological Products Co paid dividends every year for the past 16 years.

What is the dividend of Chongqing Zhifei Biological Products Co?

For the upcoming 12 months, dividends amounting to 0.42 CNY are expected. This corresponds to a dividend yield of 1.67 %.

In which sector is Chongqing Zhifei Biological Products Co located?

Chongqing Zhifei Biological Products Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chongqing Zhifei Biological Products Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chongqing Zhifei Biological Products Co from 12/25/2024 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 12/25/2024.

When did Chongqing Zhifei Biological Products Co pay the last dividend?

The last dividend was paid out on 12/25/2024.

What was the dividend of Chongqing Zhifei Biological Products Co in the year 2024?

In the year 2024, Chongqing Zhifei Biological Products Co distributed 0.333 CNY as dividends.

In which currency does Chongqing Zhifei Biological Products Co pay out the dividend?

The dividends of Chongqing Zhifei Biological Products Co are distributed in CNY.

Scope 1 - Direct Emissions	11,714.8
Scope 2 - Indirect emissions from purchased energy	83,594.8
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions	95,309.6
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Percentage of female employees	39.49
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

Chongqing Zhifei Biological Products Co Ticker	Chongqing Zhifei Biological Products Co FIGI
300122:CH	BBG000RYV885
300122:CS	BBG0014JBSL4
300122:C2	BBG00F139TV1

Access the world's leading financial data and tools

Price

Price

Ticker300122.SZ

ISINCNE100000V20

Chongqing Zhifei Biological Products Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Chongqing Zhifei Biological Products Co Stock Price History

Chongqing Zhifei Biological Products Co Revenue, EBIT, Net Income CNE100000V20 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Chongqing Zhifei Biological Products Co Revenue, EBIT and net profit per share

Chongqing Zhifei Biological Products Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Chongqing Zhifei Biological Products Co stock margins CNE100000V20 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Chongqing Zhifei Biological Products Co Margin History

Chongqing Zhifei Biological Products Co Stock Sales Revenue, EBIT, Earnings per Share CNE100000V20 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Chongqing Zhifei Biological Products Co Revenue, EBIT and net profit per share

Chongqing Zhifei Biological Products Co business model

Chongqing Zhifei Biological Products Co SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Chongqing Zhifei Biological Products Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Chongqing Zhifei Biological Products Co historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Chongqing Zhifei Biological Products Co shares outstanding CNE100000V20 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Chongqing Zhifei Biological Products Co stock splits

Chongqing Zhifei Biological Products Co dividend history and estimates CNE100000V20 ·

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Chongqing Zhifei Biological Products Co Dividend History

Ticker
300122.SZ

ISIN
CNE100000V20